Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2020-07-21
2023-01-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Improved joint function and gait pattern
* Reduction of the risk of falling or reduction of energy expenditure during physiological gait
Evaluation of the increase in maximal effort tolerance
· Improved cognitive performances
Evaluation of the impact on the quality of life of the patient and family members
Identification of morpho-functional markers predictive of clinical and rehabilitative out-come through neuroimaging study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of the Mechanical Peripheral Stimulation for Parkinson's Disease Rehabilitation
NCT02594540
Intensive Multidisciplinary Rehabilitation and Biomarkers in Parkinson's Disease
NCT05452655
Pain and Autonomic Symptoms in Parkinson's Disease and Atypical Parkinsonisms
NCT05748028
Analysis of Postural Transitions in Subjects Affected by Parkinson Disease
NCT05329987
Free-living Monitoring of Parkinson's Disease Using Smart Objects
NCT05830253
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Improved joint function and gait pattern Reduction of the risk of falling or reduction of energy expenditure during physiological gait Evaluation of the increase in maximal effort tolerance
· Improved cognitive performances
Evaluation of the impact on the quality of life of the patient and family members
Identification of morpho-functional markers predictive of clinical and rehabilitative out-come through neuroimaging study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control GROUP
This group will perform 8 continuous weeks of treatment, 5 days a week, for a total of 180 minutes, including muscle stretching, joint range increase with passive and active assisted mobilization sessions of the scapulohumeral and pelvic girdles. Motor coordination exercises. Postural exercises with exercises for trunk control in sitting and standing positions with feedback and feed-forward techniques. gait training; gait training; proprioceptive exercises and exercises to maintain static and dynamic balance in monopodalica; strengthening of trunk muscles; postural exercises, muscle relaxation/stretching, release of the tracks; re-education in postural passages and transfers with fall prevention strategies.
No interventions assigned to this group
irma group
This group will perform 8 continuous weeks of treatment, 5 days a week, for a total of 180 minutes, including muscle stretching, increasing joint range with assisted passive and active mobilisation sessions of the scapulohumeral and pelvic girdles. Motor coordination exercises. Postural exercises with exercises for trunk control in sitting and standing with feedback and feed-forward technique. Gait training; gait training; proprioceptive exercises and static and dynamic balance maintenance in monopodalics; trunk muscle strengthening; postural exercises, muscle relaxation/relaxation, caterpillar release; re-education in postural transitions and transfers with fall prevention strategies. Prior to neuromotor rehabilitation treatment, the subjects will undergo rehabilitation training using the NIRVANA augmentative reality system.
IRMA
For patients in an advanced state of illness, advanced neuromotor rehabilitation treatment included 1) robot therapies, 2) specific water courses (e.g. walking pools, hydrokinesiotherapy pools, etc.), 3) advanced cognitive treatments (e.g. virtual reality courses); 4) augmentative immersive therapy in a virtual environment; 5) courses also dedicated to social reintegration and inclusive activities (theatre-therapy, art-therapy, dance-therapy, agro-therapy, etc.).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IRMA
For patients in an advanced state of illness, advanced neuromotor rehabilitation treatment included 1) robot therapies, 2) specific water courses (e.g. walking pools, hydrokinesiotherapy pools, etc.), 3) advanced cognitive treatments (e.g. virtual reality courses); 4) augmentative immersive therapy in a virtual environment; 5) courses also dedicated to social reintegration and inclusive activities (theatre-therapy, art-therapy, dance-therapy, agro-therapy, etc.).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No need for a walking aid;
* Mini-Mental State Examination (MMSE) score \>24;
* Effective dopaminergic pharmacological control;
* Absence of other relevant neurological comorbidities;
* Absence of postural deformities (and/or Pisa syndrome);
* Absence of severe cardiological pathologies (exertional angina, severe decompensation).
* Ability to travel to the rehabilitation treatment site independently or with support
Exclusion Criteria
* presence of severe heart and/or lung disease;
* presence of therapeutic regimen in the definition phase;
* impaired joint and/or motor function to follow a proposed rehabilitation treatment programme
* contraindications to performing MRI scans
* undergoing rehabilitation therapy in the 3 months preceding enrolment.
60 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IRCCS Centro Neurolesi Bonino Pulejo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS Centro Neurolesi "Bonino-Pulejo"
Messina, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
I.R.M.A.
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.